04:07 PM EDT, 10/08/2024 (MT Newswires) -- Simon Sturge, Director, on October 04, 2024, sold 171,000 shares in Moonlake Immunotherapeutics ( MLTX ) for $9,186,120. Following the Form 4 filing with the SEC, Sturge has control over a total of 171,980 shares of the company, with 171,980 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1821586/000121390024086271/xslF345X05/ownership.xml